Deep Track Capital, LP - 21 Jul 2025 SCHEDULE 13G Report for Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TARS)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TARS
Shares outstanding
42,017,143 shares
Disclosed Ownership
2,352,960 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
28 Jul 2025, 17:00:30 UTC
Date of event
21 Jul 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.6% 2,352,960 0 2,352,960 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.6% 2,352,960 0 2,352,960 /s/ David Kroin David Kroin, Director
David Kroin 5.6% 2,352,960 0 2,352,960 /s/ David Kroin David Kroin